Business Results Fiscal Year Ended March 31, 2026

from the beginning

Business Results Fiscal Year Ended March 31, 2026

• Disclaimer

• Our Approach under the New Management Structure

• Index

1. Executive Summary

• Executive Summary (Fiscal Year Ended March 31, 2026)

• Executive Summary (Forecast for Fiscal Year Ending March 31, 2027)

2. Business Results, Fiscal Year Ended March 31, 2026

• Financial Highlights (Year on Year)

• Breakdown of Net Sales (by Business and Field)

• Breakdown of Net Sales (by Destination and Product Type)

• Information by Destination (Americas)

• Information by Destination (EMEA)

• Information by Destination (China

• Outlook for China

• Changes in the Testing Market Environment in China

• Information by Destination (AP)

• Information by Destination (Japan)

• Breakdown of Operating Profit (Year on Year)

• Goodwill Impairment Losses at Consolidated Subsidiaries

• Breakdown of Changes in the Consolidated Statement of Financial Position

• Cash Flows

• Proposed Dividend for the Fiscal Year Ended March 31, 2026

3. Strategic Themes under the Mid-Term Management Plan

• Accelerated Rollouts in the Hemostasis Field

• Business Expansion in Emerging Markets

• Strengthening the Competitiveness of the Diagnostics Business

• Succession and Future Expansion in the Clinical Chemistry Field

• Initiatives to Improve Profitability

• Enhance Profitability through Reforms to the Value Chain

• Review the Business Portfolio

4. Financial Forecast for the Fiscal Year Ending March 31, 2027

• Financial Forecast for the Fiscal Year Ending March 31, 2027

• Breakdown of Net Sales and Operating Profit for the Fiscal Year Ending March 31, 2027

• Capital Allocation (Outlook for the Fiscal Year Ending March 31, 2027)

• Dividend Forecast for the Fiscal Year Ending March 31, 2027

(Appendix)

• Quarterly Results for the Fiscal Year Ended March 31, 2026

• Financial Forecast for the Fiscal Year Ending March 31, 2027 (Sales by Business, Field, and Destination)

• Highlights (April 2025 to April 2026)

Together for a better healthcare journey